Sun Pharm Inds Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUN PHARM INDS, and when can generic versions of SUN PHARM INDS drugs launch?
SUN PHARM INDS has two hundred and twenty-five approved drugs.
There are three US patents protecting SUN PHARM INDS drugs. There are eleven tentative approvals on SUN PHARM INDS drugs.
There are five patent family members on SUN PHARM INDS drugs in three countries and two hundred and nineteen supplementary protection certificates in sixteen countries.
Summary for Sun Pharm Inds
International Patents: | 5 |
US Patents: | 3 |
Tradenames: | 167 |
Ingredients: | 158 |
NDAs: | 225 |
Drugs and US Patents for Sun Pharm Inds
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm Inds Ltd | QUINAPRIL HYDROCHLORIDE | quinapril hydrochloride | TABLET;ORAL | 090800-004 | Jun 18, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Sun Pharm Inds Inc | TICLOPIDINE HYDROCHLORIDE | ticlopidine hydrochloride | TABLET;ORAL | 075526-001 | Sep 26, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Sun Pharm Inds Ltd | AMOXICILLIN | amoxicillin | FOR SUSPENSION;ORAL | 065113-002 | Nov 29, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Sun Pharm Inds Ltd | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 077542-002 | Aug 6, 2010 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sun Pharm Inds Ltd | DOXYCYCLINE | doxycycline | CAPSULE;ORAL | 065053-002 | Nov 22, 2000 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Sun Pharm Inds
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-001 | May 25, 2012 | 8,952,064 | ⤷ Try a Trial |
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-001 | May 25, 2012 | 9,078,925 | ⤷ Try a Trial |
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-003 | May 25, 2012 | 8,952,064 | ⤷ Try a Trial |
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-001 | May 25, 2012 | 9,089,534 | ⤷ Try a Trial |
Sun Pharm Inds Inc | ABSORICA | isotretinoin | CAPSULE;ORAL | 021951-003 | May 25, 2012 | 9,078,925 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM INDS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 35 mg | ➤ Subscribe | 2015-11-25 |
➤ Subscribe | Capsules | 30 mg and 40 mg | ➤ Subscribe | 2012-12-31 |
➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-06-19 |
➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2016-05-16 |
➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-01-07 |
International Patents for Sun Pharm Inds Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2017042835 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2023175542 | ⤷ Try a Trial |
European Patent Office | 3346996 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2023281441 | ⤷ Try a Trial |
Japan | 2018530535 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Inds Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0454436 | SPC/GB96/058 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: OLANZAPINE OPTIONALLY IN THE FORM OF AN ACID ADDITION SALT; REGISTERED: UK EU/1/96/022/001 19960927; UK EU/1/96/022/002 19960927; UK EU/1/96/022/003 19960927; UK EU/1/96/022/004 19960927; UK EU/1/96/022/005 19960927; UK EU/1/96/022/006 19960927; UK EU/1/96/022/007 19960927; UK EU/1/96/022/008 19960927; UK EU/1/96/022/009 19960927; UK EU/1/96/022/010 19960927 |
1507558 | 12C0033 | France | ⤷ Try a Trial | PRODUCT NAME: ALISKIRENE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE E CELUI-CI, AMLODIPINE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI, ET HYDROCHLOROTHIAZIDE OU SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; NAT. REGISTRATION NO/DATE: EU/1/11/730/001 20111122; FIRST REGISTRATION: CH - 6167801 20110705 |
0152897 | 2001C/013 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115 |
0296560 | 2/1998 | Austria | ⤷ Try a Trial | PRODUCT NAME: DONEPEZIL UND SEINE PHARMAKOLOGISCH ANNEHMBAREN SALZE, INSBESONDERE DONEPEZIL HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-22056, 1-22057 19970728; FIRST REGISTRATION: GB PL105550006, PL105550007 19970214 |
3225249 | CA 2019 00023 | Denmark | ⤷ Try a Trial | PRODUCT NAME: DESMOPRESSIN ELLER ET ACETATSALT DERAF; NAT. REG. NO/DATE: 55858, 55859 (DK) 20160526; FIRST REG. NO/DATE: BE BE497271, BE497280 20160504 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.